Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin

✍ Scribed by Jürgen V Smit; Elke M.G.J de Jong; Candida A.E.M van Hooijdonk; Marisol E Otero; Jan B.M Boezeman; Peter C.M van de Kerkhof

• Book ID: 116579362
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 423 KB
• Volume: 51
• Category: Article
• ISSN: 1097-6787
• DOI: 10.1016/j.jaad.2004.03.002